SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Stephan Mark J.)
 

Sökning: WFRF:(Stephan Mark J.) > (2010-2014) > HTT-lowering revers...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004210naa a2200577 4500
001oai:lup.lub.lu.se:1a4c1ad4-992e-484c-8b7d-adf5686ee455
003SwePub
008160401s2014 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/43636352 URI
024a https://doi.org/10.1093/brain/awt3552 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Traeger, Ulrike4 aut
2451 0a HTT-lowering reverses Huntington's disease immune dysfunction caused by NF kappa B pathway dysregulation
264 c 2014-01-22
264 1b Oxford University Press (OUP),c 2014
520 a Huntington's disease is an inherited neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. The peripheral innate immune system contributes to Huntington's disease pathogenesis and has been targeted successfully to modulate disease progression, but mechanistic understanding relating this to mutant huntingtin expression in immune cells has been lacking. Here we demonstrate that human Huntington's disease myeloid cells produce excessive inflammatory cytokines as a result of the cell-intrinsic effects of mutant huntingtin expression. A direct effect of mutant huntingtin on the NF kappa B pathway, whereby it interacts with IKK gamma, leads to increased degradation of I kappa B and subsequent nuclear translocation of RelA. Transcriptional alterations in intracellular immune signalling pathways are also observed. Using a novel method of small interfering RNA delivery to lower huntingtin expression, we show reversal of disease-associated alterations in cellular function-the first time this has been demonstrated in primary human cells. Glucan-encapsulated small interfering RNA particles were used to lower huntingtin levels in human Huntington's disease monocytes/macrophages, resulting in a reversal of huntingtin-induced elevated cytokine production and transcriptional changes. These findings improve our understanding of the role of innate immunity in neurodegeneration, introduce glucan-encapsulated small interfering RNA particles as tool for studying cellular pathogenesis ex vivo in human cells and raise the prospect of immune cell-directed HTT-lowering as a therapeutic in Huntington's disease.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
653 a Huntington's disease
653 a immunology
653 a myeloid cells
653 a gene lowering
700a Andre, Ralph4 aut
700a Lahiri, Nayana4 aut
700a Magnusson-Lind, Annau Lund University,Lunds universitet,Biomarkörer vid hjärnsjukdomar,Forskargrupper vid Lunds universitet,Biomarkers in Brain Disease,Lund University Research Groups4 aut0 (Swepub:lu)med-a_m
700a Weiss, Andreas4 aut
700a Grueninger, Stephan4 aut
700a McKinnon, Chris4 aut
700a Sirinathsinghji, Eva4 aut
700a Kahlon, Shira4 aut
700a Pfister, Edith L.4 aut
700a Moser, Roger4 aut
700a Hummerich, Holger4 aut
700a Antoniou, Michael4 aut
700a Bates, Gillian P.4 aut
700a Luthi-Carter, Ruth4 aut
700a Lowdell, Mark W.4 aut
700a Björkqvist, Mariau Lund University,Lunds universitet,Biomarkörer vid hjärnsjukdomar,Forskargrupper vid Lunds universitet,Biomarkers in Brain Disease,Lund University Research Groups4 aut0 (Swepub:lu)farm-mbj
700a Ostroff, Gary R.4 aut
700a Aronin, Neil4 aut
700a Tabrizi, Sarah J.4 aut
710a Biomarkörer vid hjärnsjukdomarb Forskargrupper vid Lunds universitet4 org
773t Braind : Oxford University Press (OUP)g 137, s. 819-833q 137<819-833x 1460-2156x 0006-8950
856u http://dx.doi.org/10.1093/brain/awt355y FULLTEXT
856u https://academic.oup.com/brain/article-pdf/137/3/819/13797635/awt355.pdf
8564 8u https://lup.lub.lu.se/record/4363635
8564 8u https://doi.org/10.1093/brain/awt355

Hitta via bibliotek

  • Brain (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy